Core Laboratories Stock Analysis

CLB -  USA Stock  

USD 41.35  1.10  2.59%

The current price rise of Core Laboratories could raise concerns from investors as the firm it trading at a share price of 41.35 on 756,900 in volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in July. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.29. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Core Laboratories partners.
Continue to Trending Equities.

Search Stock Analysis 

The Core Laboratories stock analysis report makes it easy to digest most publicly released information about Core Laboratories and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Core Laboratories stock analysis module also helps to analyze the Core Laboratories price relationship with some important fundamental indicators such as market cap and management efficiency.

Core Laboratories Stock Analysis Notes

About 105.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.95. Core Laboratories next dividend is scheduled to be issued on the 30th of April 2021. The entity had 2:1 split on the 9th of July 2010. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories operates under Oil Gas Equipment Services classification in the United States and is traded on New York Stock Exchange. It employs 3700 people. For more info on Core Laboratories NV please contact Lawrence Bruno at 31 20 420 3191 or go to

Core Laboratories Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Core Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Core Laboratories NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Core Laboratories has very high historical volatility over the last 90 days
Core Laboratories has a strong financial position based on the latest SEC filings
Latest headline from Shareholders Are Thrilled That The Core Laboratories Share Price Increased 110 percent - Simply Wall St

Core Laboratories Upcoming and Recent Events

Earnings reports are used by Core Laboratories to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report28th of July 2021
Next Earnings Report20th of October 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End26th of January 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Core Laboratories Largest EPS Surprises

Earnings surprises can significantly impact Core Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Core Laboratories SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Core Laboratories prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Core Laboratories investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Core Laboratories specific information freely available to individual and institutional investors to make a timely investment decision.
10th of June 2021
Unclassified Corporate Event
19th of May 2021
Submission of Matters to a Vote of Security Holders
21st of April 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
16th of February 2021
Unclassified Corporate Event
12th of February 2021
Unclassified Corporate Event
11th of February 2021
Unclassified Corporate Event
10th of February 2021
Unclassified Corporate Event
27th of January 2021
Financial Statements and Exhibits. Unclassified Corporate Event. Results of Operations and Financial Condition

Core Laboratories Thematic Classifications

In addition to having Core Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Petroleum and Natural IdeaPetroleum and Natural
USA Equities from Petroleum and Natural industry as classified by Fama & French

Core Laboratories Market Capitalization

The company currently falls under 'Mid-Cap' category with total capitalization of 2.21 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Core Laboratories's market, we take the total number of its shares issued and multiply it by Core Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Core Laboratories Profitablity

Core Laboratories' profitability indicators refer to fundamental financial ratios that showcase Core Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Core Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Core Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Core Laboratories' profitability requires more research than a typical breakdown of Core Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 4.26 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is considered to be average in the sector. In the same way, it shows Net Operating Margin of 15.19 %, which entails that for every 100 dollars of revenue, it generated 0.15 of operating income.
Last ReportedProjected for 2021
Return on Average Assets(0.16) (0.16) 
Return on Average Equity(1.46) (1.58) 
Return on Invested Capital(0.11) (0.11) 
Return on Sales(0.16) (0.16) 

Management Efficiency

The entity has Return on Asset of 4.77 % which means that on every $100 spent on asset, it made $4.77 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.02 %, implying that it generated $18.02 on every 100 dollars invested. Core Laboratories management efficiency ratios could be used to measure how well core laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year Return on Average Assets is expected to grow to -0.16. In addition to that, Return on Average Equity is expected to decline to -1.58. Core Laboratories Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 568.58 Million. The current year Current Assets is expected to grow to about 194.1 M, whereas Return on Average Assets are projected to grow to (0.16) .
Last ReportedProjected for 2021
Book Value per Share 1.61  2.18 
Enterprise Value over EBIT(19.00) (19.50) 
Enterprise Value over EBITDA(26.50) (27.20) 
Price to Book Value 16.49  13.94 
Tangible Assets Book Value per Share 10.36  11.36 
Enterprise Value1.5 B1.5 B
Tangible Asset Value460.6 M434.4 M

Technical Drivers

As of the 19th of June, Core Laboratories shows the Downside Deviation of 3.57, risk adjusted performance of 0.0789, and Mean Deviation of 2.4. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Core Laboratories NV, which can be compared to its rivals. Please confirm Core Laboratories value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Core Laboratories is priced correctly, providing market reflects its regular price of 41.35 per share. Given that Core Laboratories has jensen alpha of 0.3099, we suggest you to validate Core Laboratories NV's prevailing market performance to make sure the company can sustain itself at a future point.

Core Laboratories Price Movement Analysis

The output start index for this execution was six with a total number of output elements of fifty-five. The Triangular Moving Average shows Core Laboratories double smoothed mean price over a specified number of previous prices (i.e., averaged twice). View also all equity analysis or get more info about triangular moving average overlap studies indicator.

Core Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Temeng Kwaku over a month ago via Macroaxis 
Acquisition by Temeng Kwaku of 4307 shares of Core Laboratories subject to Rule 16b-3
Van Dijken Eeuwijk Monique over two months ago via Macroaxis 
Acquisition by Van Dijken Eeuwijk Monique of 4307 shares of Core Laboratories subject to Rule 16b-3
Kevin Daniels over three months ago via Macroaxis 
Exercise or conversion by Kevin Daniels of 120 shares of Core Laboratories subject to Rule 16b-3
Gwendolyn Schreffler over three months ago via Macroaxis 
Acquisition by Gwendolyn Schreffler of 13810 shares of Core Laboratories subject to Rule 16b-3
Gwendolyn Schreffler over three months ago via Macroaxis 
Core Laboratories exotic insider transaction detected
Kevin Daniels over three months ago via Macroaxis 
Exercise or conversion by Kevin Daniels of 2600 shares of Core Laboratories subject to Rule 16b-3
Kevin Daniels over six months ago via Macroaxis 
Exercise or conversion by Kevin Daniels of 140 shares of Core Laboratories subject to Rule 16b-3
Mark Elvig over six months ago via Macroaxis 
Acquisition or disposition of Core Laboratories securities by Mark Elvig
Richard Bergmark over a year ago via Macroaxis 
Payment of 17955 shares by Richard Bergmark of Core Laboratories subject to Rule 16b-3
Richard Bergmark over a year ago via Macroaxis 
Sale by Richard Bergmark of 3218 shares of Core Laboratories
D Ogren over a year ago via Macroaxis 
Sale by D Ogren of 500 shares of Core Laboratories
Richard Bergmark over a year ago via Macroaxis 
Sale by Richard Bergmark of 200 shares of Core Laboratories

Core Laboratories Predictive Daily Indicators

Core Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Core Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Core Laboratories Forecast Models

Core Laboratories time-series forecasting models is one of many Core Laboratories' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Core Laboratories Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Core Laboratories stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Core Laboratories shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Core Laboratories. By using and applying Core Laboratories Stock analysis, traders can create a robust methodology for identifying Core Laboratories entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(0.12) (0.12) 
Gross Margin 0.23  0.26 
Profit Margin(0.20) (0.21) 
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. Core Laboratories N.V. was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories operates under Oil Gas Equipment Services classification in the United States and is traded on New York Stock Exchange. It employs 3700 people.

Current Core Laboratories Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core Laboratories analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Core Laboratories analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Core Laboratories NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Core Laboratories analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Core Laboratories stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Core Laboratories, talking to its executives and customers, or listening to Core Laboratories conference calls.
Core Laboratories Analyst Advice Details

Core Laboratories Stock Analysis Indicators

Core Laboratories NV stock analysis indicators help investors evaluate how Core Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Core Laboratories shares will generate the highest return on investment. By understating and applying Core Laboratories stock analysis, traders can identify Core Laboratories position entry and exit signals to maximize returns.
Quick Ratio1.49
Trailing Annual Dividend Rate0.04
Fifty Two Week Low13.43
Revenue Growth-28.90%
Payout Ratio9.09%
Average Daily Volume Last 10 Day470.54k
Shares Short Prior Month3.88M
Average Daily Volume In Three Month482.96k
Shares Percent Shares Out7.20%
Gross Margins20.10%
Forward Price Earnings37.65
Short Percent Of Float7.21%
Float Shares46.08M
Fifty Two Week High49.87
Fifty Day Average37.18
Enterprise Value To Ebitda24.04
Two Hundred Day Average32.68
Enterprise Value To Revenue3.65
Trailing Annual Dividend Yield0.08%
Continue to Trending Equities. Note that the Core Laboratories information on this page should be used as a complementary analysis to other Core Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Core Laboratories Stock analysis

When running Core Laboratories price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Directory
Find actively-traded Exchange Traded Funds (ETF) from around the world
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
The market value of Core Laboratories is measured differently than its book value, which is the value of Core Laboratories that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Core Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.